Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication
Release Date: March 2007
This topic is in the process of being updated. Please go to the Update in Progress section to see the latest documents available.
Summary of Recommendation
The USPSTF recommends against the routine use of aspirin and nonsteroidal anit-inflammatory drugs (NSAIDS) to prevent colorectal cancer in individuals at average risk for colorectal cancer.
|The USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits|
Internet Citation: Recommendation Summary. U.S. Preventive Services Task Force. September 2014.